Action 300363 PORTON PHARMA SOLUTIONS LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Porton Pharma Solutions Ltd.

Actions

300363

CNE100001S57

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
16,81 CNY -1,70% Graphique intraday de Porton Pharma Solutions Ltd. +3,32% -33,16%
26/04 Porton Pharma Solutions Ltd. déclare ses résultats pour le premier trimestre clos le 31 mars 2024 CI
26/04 Porton Pharma Solutions Ltd. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility
China’s Porton to set up biotech park in Slovenia’s Menges
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300363
  4. Actualités Porton Pharma Solutions Ltd.
  5. Autres langues